User Tools

Site Tools


research:project_proposal_template

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision
Previous revision
research:project_proposal_template [2014/12/02 18:21]
jduke
research:project_proposal_template [2015/02/16 20:45] (current)
rkboyce
Line 1: Line 1:
- +====== ​Incidence of exposure to drugs for which pre-emptive pharmacogenomic testing is available  ​======
-To create a new study, login to the Wiki and then: +
- +
-1) Click the Edit (Pencil) button to the right of this page.  Copy all the text.   +
- +
-2) Go to the [[research:​protocols_in_development|Protocols under Development]] page. Click Edit. +
- +
-3) Add the name of your study to the list.  Hit Save. +
- +
-4) Click on your new study'​s page.  Hit edit.  Paste in the text you copied and edit away! +
- +
-====== ​<Your Study Name>======+
  
 <WRAP box justify round> <WRAP box justify round>
  
-**Objective:​** //<​summarize study objective>//​+**Objective:​** ​Derive data that large healthcare organizations can combine data on risks of adverse events ​ and cost data to conduct cost-effectiveness ​cost-benefit analyses for pre-emptive pharmacogenomics testing
  
-**Rationale:​** ​//<​summarize ​study rationale>//​+**Rationale:​** ​Very few studies have been conducted that report on the potential return on investment for pre-emptive pharmacogenomics testing. The studies that have been published ​ suggest that pre-emptive pharmacogenomics testing may produce a return on investment but much depends on if a sufficient number of drugs with pharmacogenes are covered by a single test. Since the current data are limited to relatively localized settings and might not be of generalizable use to other health organizations,​ it's of interest to implement a new study using the OHDSI research network. ​
  
-**Project Lead(s):​** ​//<​initial proposerslist may grow>//+**Project Lead(s):​** ​Richard D. BoyceMatthias Samwald, Patrick Ryan, (seeking other collaborators)
  
-**Coordinating Institution(s):​** ​//<your institution>//​+**Coordinating Institution(s):​** ​University of Pittsburgh, Medical University of Vienna
  
 ** Additional Participants:​** ​ //<​usually blank initially, list will grow as individuals are added who are not project leads>// ** Additional Participants:​** ​ //<​usually blank initially, list will grow as individuals are added who are not project leads>//
Line 26: Line 15:
 **Full Protocol:** //<if available, a link to protocol. ​ not necessary for initial planning>//​ **Full Protocol:** //<if available, a link to protocol. ​ not necessary for initial planning>//​
  
-**Initial Proposal Date:​**  ​+**Initial Proposal Date:​**  ​2/16/2015
  
 **Launch Date:​** ​ //<fill out once finalized>//​ **Launch Date:​** ​ //<fill out once finalized>//​
Line 37: Line 26:
  
 ===== Requirements ===== ===== Requirements =====
-**CDM:​** ​//<V4 or V5 or both>//+**CDM:** V4 or V5
  
-**Table Accessed:​**  ​//<e.g.persondrug_exposureobservations>//​+**Table Accessed:​**  ​DRUG_EXPOSURECONCEPT_ANCESTORCONCEPT_RELATIONSHIPPERSON
  
 **Database Dialects:** SQL Server, Postgres, Oracle **Database Dialects:** SQL Server, Postgres, Oracle
  
-**Software:​** ​ //<<​e.g., ​R>// ​+**Software:​** ​SQL and 
    
 ===== Code =====  ===== Code ===== 
-[[https://​github.com/​OHDSI/​StudyProtocols]]+[[https://​github.com/​OHDSI/​StudyProtocols/​tree/​master/​Proposed%20Study%203%20-%20Incidence%20of%20exposure%20to%20PGx%20drugs|GitHub code for Proposed Study 3 - Incidence of exposure to PGx drugs]]
  
 ===== Discussion =====  ===== Discussion ===== 
Line 52: Line 41:
  
 ===== Datasets Run =====  ===== Datasets Run ===== 
-  * <list your own datasets or leave blank>+  * Truven CCAE in the IMEDS lab 
 +  * Truven MDCD in the IMEDS lab 
 +  * Truven MDCR in the IMEDS lab
  
  
 ~~NOTOC~~ ~~NOTOC~~
research/project_proposal_template.1417544505.txt.gz · Last modified: 2014/12/02 18:21 by jduke